Literature DB >> 34134706

Histiocytic pleural effusion: the strong clue to malignancy.

Ganghee Chae1, Jae-Bum Jun2, Hwa Sik Jung3, Chui Yong Park1, Jin Hyoung Kim4, Byung Ju Kang4, Hyeon Hui Kang4, Seung Won Ra4, Kwang Won Seo4, Yangjin Jegal4, Jong Joon Ahn4, Sang Hyuk Park5, Taehoon Lee6.   

Abstract

BACKGROUND: There have been many studies on the clinical characteristics of neutrophilic, lymphocytic, and/or eosinophilic pleural effusion. While caring for patients with pleural effusion, we found that histiocytic pleural effusion (HisPE) was not uncommon. However, few studies have explored HisPE. The purpose of the present study was to determine the clinical characteristics and etiologies of HisPE.
METHODS: In this retrospective study, HisPE was defined as pleural fluid white blood cells comprised of ≥ 50% histiocytes. Using a clinical data warehouse, patients with HisPE among all patients aged >18 years who underwent thoracentesis and pleural fluid analysis between January 2010 and December 2019 at Ulsan University Hospital were enrolled. A total of 295 (9.0%) of 3279 patients who underwent thoracentesis were identified as HisPE patients. Among them, 201 with exudative HisPE were included. Clinical characteristics and etiologies were extracted from medical records and analyzed.
RESULTS: Among the 201 patients with exudative HisPE, the major causes were malignant pleural effusion (n = 102 [50.7%]), parapneumonic effusion (n = 9 [4.5%]), and tuberculous pleurisy (n = 9 [4.5%]). In the 102 patients with malignant pleural effusion, the main types of cancer were lung (n = 42 [41.2%]), breast (n = 16 [15.7%]), and stomach cancer (n = 11 [10.8%]). Among lung cancers, adenocarcinoma (n = 34 [81.0%]) was the most common histology.
CONCLUSIONS: The leading cause of exudative HisPE was malignancy, particularly lung cancer. Physicians should consider the possibility of malignant disease if histiocytes are predominantly present in pleural effusion.

Entities:  

Keywords:  Exudate; Histiocytes; Malignancy; Pleural effusion; Thoracentesis

Year:  2021        PMID: 34134706     DOI: 10.1186/s12957-021-02296-1

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  16 in total

1.  Unusual histiocytes in a pleural effusion: signature of a rare disease.

Authors:  Christelle El Khoury; Hussein Farhat
Journal:  Blood       Date:  2019-07-11       Impact factor: 22.113

Review 2.  Pleural effusions.

Authors:  José M Porcel; Richard W Light
Journal:  Dis Mon       Date:  2013-02       Impact factor: 3.800

3.  Diagnostic significance of pleural fluid pH and PCO2.

Authors:  R W Light; M I MacGregor; W C Ball; P C Luchsinger
Journal:  Chest       Date:  1973-11       Impact factor: 9.410

4.  Pleural effusions: the diagnostic separation of transudates and exudates.

Authors:  R W Light; M I Macgregor; P C Luchsinger; W C Ball
Journal:  Ann Intern Med       Date:  1972-10       Impact factor: 25.391

Review 5.  Pleural effusions.

Authors:  Richard W Light
Journal:  Med Clin North Am       Date:  2011-09-25       Impact factor: 5.456

6.  Reactive histiocytic proliferation in the pleural fluid mimicking metastatic signet ring adenocarcinoma.

Authors:  Fatima Mir; Anam Naumaan; Hussein Alnajar; Arlen Brickman; Vijaya Reddy; Ji-Weon Park; Paolo Gattuso
Journal:  Diagn Cytopathol       Date:  2018-01-08       Impact factor: 1.582

7.  Volume and cellular content of normal pleural fluid in humans examined by pleural lavage.

Authors:  M Noppen; M De Waele; R Li; K V Gucht; J D'Haese; E Gerlo; W Vincken
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

8.  Primary mediastinal histiocytic sarcoma presenting as pleural effusion.

Authors:  Jie-Yang Jhuang; Wei-Yu Chen; Shih-Sung Chuang
Journal:  Diagn Cytopathol       Date:  2018-05-13       Impact factor: 1.582

9.  Comparison of the incidence between tuberculosis and nontuberculous mycobacterial disease after gastrectomy.

Authors:  C H Kim; K H Im; S S Yoo; S Y Lee; S I Cha; H Y Jung; J Y Park; W Yu; J Lee
Journal:  Infection       Date:  2014-05-10       Impact factor: 3.553

Review 10.  Eosinophilic pleural effusions.

Authors:  Ioannis Kalomenidis; Richard W Light
Journal:  Curr Opin Pulm Med       Date:  2003-07       Impact factor: 3.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.